Floatz logo

Selenium

Follicular Lymphoma

Oslo University HospitalSmall moleculePhase 2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

210 Active assets in the Follicular Lymphoma cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2/3BBB
Romidepsin
City of Hope Medical Center
Phase 2BBB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BBB
Recombinant Human Hyaluronidase
National Cancer Institute (NCI)
Phase 3BBB
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BBB

View all 50 →

Same molecule, other indications

Selenium is also rated in:

chronic prostatitisDormant
BB
Indicative ·
69 / 100
View asset →
Chronic Prostatitis With Chronic Pelvic Pain SyndromeDormant
BB
Indicative ·
69 / 100
View asset →
precancerous conditionDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →